Skip to content

Parainfluenza Virus Human IgG Assay Control BC126G



  • Virion/Serion Diagnostic Kit Control for research use (RUO)
  • Parainfluenza Virus Human IgG Assay Control, recombinant
  • Applications: ELISA
  • Suitable for IgG detection
  • Ready-to-use; pre-diluted for SERION ELISA classic and SERION ELISA antigen assays
  • 3 mL

Order now and receive on May 30, 2024

Calculate shipping price

Please fill in the fields below with the shipping destination details in order to calculate the shipping cost.

Weight1 lbs
Dimensions9 × 5 × 2 in

Parainfluenza Virus reactive IgG

species reactivity

Parainfluenza Virus



assay type

Indirect & quantitative

Research area
Infectious Disease
Store at 2-8°C.
Associated products
Parainfluenza Virus Type 1 Antigen (BA1261VS)
Parainfluenza Virus Type 2 Antigen (BA1262VS)
Parainfluenza Virus Type 3 Control Antigen (BA1263VS)
Parainfluenza Virus Human IgA Assay Control (BC126A)
Parainfluenza Virus Human IgG Assay Control (BC126G)
Parainfluenza Virus IgA ELISA Kit (ESR126A)
Parainfluenza Virus IgG ELISA Kit (ESR126G)
target relevance
Parainfluenza Virus
Structure and strains
Human parainfluenza viruses (HPIVs) are the viruses that cause human parainfluenza. HPIVs are a paraphyletic group of four distinct single-stranded RNA viruses belonging to the Paramyxoviridae family. These viruses are closely associated with both human and veterinary disease. Virions are approximately 150 250 nm in size and contain negative sense RNA with a genome encompassing about 15,000 nucleotides.
Parainfluenza Viruses are worldwide distributed (-)ssRNA viruses belonging to the family of Paramyxoviridae. Currently, four serotypes have been identified. The Parainfluenza Virus types 1 to 3 are clinically most significant.

Human Parainfluenza Viruses are a common causative agent of infections of the respiratory tract, particularly in infants and children. Transmission of the viruses occurs by droplet infections. Parainfluenza Viruses cause mild to severe infections in the lower and upper respiratory tract which may manifest as rhinitis, cough, fever, non-diphtheric croup (acute laryngotracheobronchitis) or pneumonia. In infants, excessive formation of mucus and internal airway obstruction can occur. In adults, an infection usually results in mild catarrh of the upper respiratory tract.
Detection and diagnosis
While the majority of patients infected with Parainfluenza Viruses develop IgG antibodies, IgM antibodies are detectable in approximately 50% of cases. Thus, the specific detection of IgA antibodies should be performed analogous to other infectious diseases of the respiratory tract (e.g. Respiratory Syncytial Virus infections). Particularly in children under three years of age the combined use of IgG and IgA detection is recommended.



Published literature highly relevant to the biological target of this product and referencing this antibody or clone are retrieved from PubMed database provided by The United States National Library of Medicine at the National Institutes of Health.



relevant to this product
BC126G protocol


No results found


There are no reviews yet.

Be the first to review “Parainfluenza Virus Human IgG Assay Control BC126G”